Not applicableStudy completedNCT00896896What this trial is testingImmunoreactivity to Cetuximab in Cancer PatientsWho this might be right forColorectal CancerHead and Neck Cancer Vanderbilt-Ingram Cancer Center 538
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07778368What this trial is testingA Multicenter, Prospective, Phase II Study of TROP-2 ADC in Combination With Toripalimab for Resectable Locally Advanced Oral Squamous Cell CarcinomaWho this might be right forOral Squamous Cell Carcinoma (OSCC) Shanghai East Hospital 20
Very early researchLooking for participantsNCT06914999What this trial is testingComparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck CancerWho this might be right forClinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+13 more Emory University
Testing effectiveness (Phase 2)Looking for participantsNCT05269381What this trial is testingPersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more Mayo Clinic 138
Testing effectiveness (Phase 2)Study completedNCT00971932What this trial is testingStudy of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)Who this might be right forSquamous Cell Carcinoma of the Head and Neck Merck KGaA, Darmstadt, Germany 33
Not applicableStudy completedNCT00828516What this trial is testingUsing Traditional Acupuncture in the Management of Cancer Treatment Related LymphoedemaWho this might be right forBreast CancerHead and Neck CancerLymphedema East and North Hertfordshire NHS Trust 56
Testing effectiveness (Phase 2)Study completedNCT02289209What this trial is testingReirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and NeckWho this might be right forRecurrent Head and Neck CancerCarcinoma, Squamous Cell of Head and Neck Dan Zandberg 48
Testing effectiveness (Phase 2)Study completedNCT04212598What this trial is testingThe Value of Sintilimab Consolidation Therapy After Definitive Concurrent Chemoradiotherapy for Locally Advanced Thoracic Esophageal CancerWho this might be right forEsophageal Squamous Cell Carcinoma Wuhan University 40
Testing effectiveness (Phase 2)Study completedNCT00005087What this trial is testingPaclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck CancerWho this might be right forHead and Neck Cancer Radiation Therapy Oncology Group 105
Testing effectiveness (Phase 2)Looking for participantsNCT06088381What this trial is testingSelective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)Who this might be right forHead and Neck CancerHead and Neck Squamous Cell CarcinomaOropharynx Cancer+2 more University of Maryland, Baltimore 61
Testing effectiveness (Phase 2)Ended earlyNCT00707473What this trial is testingDocetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus CancerWho this might be right forLocally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell CarcinomaNasal Cavity and Paranasal Sinus Poorly Differentiated CarcinomaSinonasal Undifferentiated Carcinoma+4 more M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)Study completedNCT00639769What this trial is testingIrinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forHead and Neck Cancer Vanderbilt-Ingram Cancer Center 41
Large-scale testing (Phase 3)Ended earlyNCT00190554What this trial is testingA Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal NeoplasmsCarcinoma, Squamous Cell Japan Clinical Oncology Group 330
Testing effectiveness (Phase 2)Study completedNCT02207439What this trial is testingPhase II Trial of Nelfinavir With Concurrent Chemoradiotherapy in Squamous Cell Carcinoma of the Head and NeckWho this might be right forHead and Neck Squamous Cell Carcinoma Abramson Cancer Center at Penn Medicine 18
Early research (Phase 1)Study completedNCT00404339What this trial is testingVaccine Therapy in Treating Patients With Head and Neck CancerWho this might be right forHead and Neck Cancer Robert Ferris 17
Large-scale testing (Phase 3)Study completedNCT00002839What this trial is testingCombination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or LarynxWho this might be right forHead and Neck Cancer European Organisation for Research and Treatment of Cancer - EORTC 564
Testing effectiveness (Phase 2)Study completedNCT05156970What this trial is testingCamrelizumab in Combination With Chemotherapy or Apatinib Mesylate as First-Line Treatment for R/M HNSCCWho this might be right forRecurrent Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell Carcinoma Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 81
Testing effectiveness (Phase 2)Ended earlyNCT00982696What this trial is testingTreatment of Advanced Head and Neck CancerWho this might be right forCarcinoma, Squamous Cell of Head and Neck Milton S. Hershey Medical Center 5
Testing effectiveness (Phase 2)Study completedNCT00544362What this trial is testingFluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by SurgeryWho this might be right forEsophageal Cancer Federation Francophone de Cancerologie Digestive 33
Testing effectiveness (Phase 2)Study completedNCT00022594What this trial is testingLiposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck CancerWho this might be right forHead and Neck Cancer European Organisation for Research and Treatment of Cancer - EORTC 50